TrialCancer medicine2019

The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials.

Frederick Lansigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.